Indeed, the enhanced mesenchymal properties in GBM cells with ABL ablation is paralleled by the loss of stem cell markers, such as NANOG, NESTIN, CD133, BMI, SOX9, SOX2, and OCT4, and reduced neurosphere formation. This evidence concerns the gene POU5F1 and glioblastoma.